Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 37.0x - 40.9x | 39.0x |
| Selected Fwd Ps Multiple | 38.1x - 42.1x | 40.1x |
| Fair Value | ₺80.50 - ₺88.98 | ₺84.74 |
| Upside | -16.7% - -7.9% | -12.3% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | - | IBSE:CONSE |
| Kartal Yenilenebilir Enerji Uretim A.S. | - | IBSE:KARYE |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | - | IBSE:BIOEN |
| Zorlu Enerji Elektrik Üretim A.S. | - | IBSE:ZOREN |
| Aydem Yenilenebilir Enerji A.S. | - | IBSE:AYDEM |
| Pamukova Yenilenebilir Elektrik Uretim A.S. | - | IBSE:PAMEL |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| CONSE | KARYE | BIOEN | ZOREN | AYDEM | PAMEL | |||
| IBSE:CONSE | IBSE:KARYE | IBSE:BIOEN | IBSE:ZOREN | IBSE:AYDEM | IBSE:PAMEL | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | NM- | 58.1% | 96.4% | 29.3% | 40.6% | 54.0% | ||
| 3Y CAGR | 54.4% | 63.3% | 84.5% | 36.6% | 74.4% | 93.4% | ||
| Latest Twelve Months | -19.7% | 48.2% | -16.6% | -24.7% | -28.3% | -15.1% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 11.0% | 56.4% | 20.3% | 14.4% | -5.7% | 97.6% | ||
| Prior Fiscal Year | 17.7% | 1.8% | 42.5% | 39.3% | -20.1% | 343.9% | ||
| Latest Fiscal Year | 11.1% | 61.1% | 3.7% | -15.0% | -178.8% | -527.3% | ||
| Latest Twelve Months | 11.1% | 61.1% | 3.7% | -15.0% | -178.8% | -527.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 12.3x | 7.6x | 50.1x | 9.3x | 8.5x | 27.5x | ||
| Price / LTM Sales | 1.5x | 3.9x | 3.4x | 0.5x | 1.8x | 45.1x | ||
| LTM P/E Ratio | 13.8x | 6.3x | 92.0x | -3.6x | -1.0x | -8.5x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.5x | 1.8x | 3.9x | |||||
| Historical LTM P/S Ratio | 40.9x | 50.3x | 299.3x | |||||
| Selected Price / Sales Multiple | 37.0x | 39.0x | 40.9x | |||||
| (x) LTM Sales | 67 | 67 | 67 | |||||
| (=) Equity Value | 2,468 | 2,597 | 2,727 | |||||
| (/) Shares Outstanding | 31.1 | 31.1 | 31.1 | |||||
| Implied Value Range | 79.36 | 83.53 | 87.71 | |||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 79.36 | 83.53 | 87.71 | 96.60 | ||||
| Upside / (Downside) | -17.9% | -13.5% | -9.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CONSE | KARYE | BIOEN | ZOREN | AYDEM | PAMEL | |
| Value of Common Equity | 2,089 | 1,498 | 9,075 | 16,250 | 11,769 | 3,004 | |
| (/) Shares Outstanding | 771.0 | 55.0 | 500.0 | 5,000.0 | 698.9 | 31.1 | |
| Implied Stock Price | 2.71 | 27.24 | 18.15 | 3.25 | 16.84 | 96.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2.71 | 27.24 | 18.15 | 3.25 | 16.84 | 96.60 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |